Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$110.31 - $140.45 $6.26 Million - $7.97 Million
56,753 New
56,753 $6.43 Million
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $126,250 - $202,343
-1,467 Reduced 11.03%
11,830 $1.1 Million
Q2 2023

Aug 09, 2023

BUY
$112.47 - $130.98 $1.5 Million - $1.74 Million
13,297 New
13,297 $1.71 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Agf Management LTD Portfolio

Follow Agf Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Agf Management LTD with notifications on news.